Supernus Pharmaceuticals, Inc. earnings per share and revenue

SUPN earnings per share for the last quarter are 0.88 USD whereas the estimation was 0.55 USD which accounts for 59.50% surprise. Company revenue for the same period amounts to 164.31 M USD despite the estimated figure of 155.03 M USD. Estimated earnings per share for the next quarter are 0.26 USD, and revenue is expected to reach 145.83 M USD. Also watch annual changes over time to get a bigger picture of SUPN earnings per share and revenue dynamics.